V. Acuña, A. Ginebreda, and J. R. Mor, Balancing the health benefits and environmental risks of pharmaceuticals: diclofenac as an example, Environment International, vol.85, pp.327-333, 2015.

C. Grandclément, I. Seyssiecq, and A. Piram, From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: a review, Water Research, vol.111, pp.297-317, 2017.

D. J. Lapworth, N. Baran, M. E. Stuart, and R. S. Ward, Emerging organic contaminants in groundwater: a review of sources, fate and occurrence, Environmental Pollution, vol.163, pp.287-303, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00687127

L. Arpin-pont, M. J. Bueno, E. Gomez, and H. Fenet, Occurrence of PPCPs in the marine environment: a review, Environmental Science and Pollution Research, vol.23, issue.6, pp.4978-4991, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02086817

E. Vulliet and C. Cren-olivé, Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption, Environmental Pollution, vol.159, issue.10, pp.2929-2934, 2011.

N. Vieno and M. Sillanpää, Fate of diclofenac in municipal wastewater treatment plant-a review, Environment International, vol.69, pp.28-39, 2014.

L. N. Nguyen, L. D. Nghiem, B. K. Pramanik, and S. Oh, Cometabolic biotransformation and impacts of the antiinflammatory drug diclofenac on activated sludge microbial communities, Science of e Total Environment, vol.657, pp.739-745, 2019.

Y. Zhang, S. Geißen, and C. Gal, Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies, Chemosphere, vol.73, issue.8, pp.1151-1161, 2008.

N. Tadkaew, F. I. Hai, J. A. Mcdonald, S. J. Khan, and L. D. Nghiem, Removal of trace organics by MBR treatment: the role of molecular properties, Water Research, vol.45, issue.8, pp.2439-2451, 2011.

Z. Huang, G. Chen, and G. Zeng, Toxicity mechanisms and synergies of silver nanoparticles in 2,4-dichlorophenol degradation by Phanerochaete chrysosporium, Journal of Hazardous Materials, vol.321, pp.37-46, 2017.

Z. Huang, G. Chen, and G. Zeng, Polyvinyl alcoholimmobilized Phanerochaete chrysosporium and its application in the bioremediation of composite-polluted wastewater, Journal of Hazardous Materials, vol.289, pp.174-183, 2015.

T. Hata, S. Kawai, H. Okamura, and T. Nishida, Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation, Biodegradation, vol.21, issue.5, pp.681-689, 2010.

E. Marco-urrea, M. Pérez-trujillo, C. Cruz-morató, G. Caminal, and T. Vicent, Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR, Journal of Hazardous Materials, vol.176, issue.1-3, pp.836-842, 2010.

A. I. Rodarte-morales, G. Feijoo, M. T. Moreira, and J. M. Lema, Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi, World Journal of Microbiology and Biotechnology, vol.27, issue.8, pp.1839-1846, 2011.

D. R. Olicón-hernández, R. L. Camacho-morales, C. Pozo, J. González-lópez, and E. Aranda, Evaluation of diclofenac biodegradation by the ascomycete fungus Penicillium oxalicum at flask and bench bioreactor scales, Science of e Total Environment, vol.662, pp.607-614, 2019.

D. Domaradzka, U. Guzik, and D. Wojcieszy?ska, Biodegradation and biotransformation of polycyclic non-steroidal anti-inflammatory drugs, Reviews in Environmental Science and Bio/Technology, vol.14, issue.2, pp.229-239, 2015.

A. Langenhoff, N. Inderfurth, and T. Veuskens, Microbial removal of the pharmaceutical compounds ibuprofen and diclofenac from wastewater, BioMed Research International, vol.2013, 2013.

Q. Liu, M. Li, and X. Liu, Removal of sulfamethoxazole and trimethoprim from reclaimed water and the biodegradation mechanism, Frontiers of Environmental Science & Engineering, vol.12, issue.6, 2018.

R. Hunter, S. Ekunwe, D. Dodor, H. Hwang, and L. Ekunwe, Bacillus subtilis is a potential degrader of pyrene and benzo[a]pyrene, International Journal of Environmental Research and Public Health, vol.2, issue.2, pp.267-271, 2005.

L. Lonappan, S. K. Brar, R. K. Das, M. Verma, and R. Y. Surampalli, Diclofenac and its transformation products: environmental occurrence and toxicity-a review, Environment International, vol.96, pp.127-138, 2016.

T. Haap, R. Triebskorn, and H. Köhler, Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction, Chemosphere, vol.73, issue.3, pp.353-359, 2008.

B. Quinn, W. Schmidt, K. O'rourke, and R. Hernan, Effects of the pharmaceuticals gemfibrozil and diclofenac on biomarker expression in the zebra mussel (Dreissena polymorpha) and their comparison with standardised toxicity tests, Chemosphere, vol.84, issue.5, pp.657-663, 2011.

J. Martín, D. Camacho-muñoz, J. L. Santos, I. Aparicio, and E. Alonso, Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal, Journal of Hazardous Materials, pp.40-47, 2012.

B. Ferrari, N. Paxéus, R. L. Giudice, A. Pollio, and J. Garric, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicology and Environmental Safety, vol.55, issue.3, pp.359-370, 2003.

M. Cleuvers, Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid, Ecotoxicology and Environmental Safety, vol.59, issue.3, pp.309-315, 2004.

R. M. Atlas, Handbook of Microbiological Media, 2010.

R. Meribout, Y. Zuo, and A. A. Khodja, Photocatalytic degradation of antiepileptic drug carbamazepine with bismuth oxychlorides (BiOCl and BiOCl/AgCl composite) in water: efficiency evaluation and elucidation degradation pathways, Journal of Photochemistry and Photobiology A: Chemistry, vol.328, pp.105-113, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01436760

A. Palyzová, J. Zahradník, and H. Mare?ová, Potential of the strain Raoultella sp. KDF8 for removal of analgesics, Folia Microbiologica, vol.63, issue.3, pp.273-282, 2017.

V. S. Bessa, I. S. Moreira, M. E. Tiritan, and P. M. Castro, Enrichment of bacterial strains for the biodegradation of diclofenac and carbamazepine from activated sludge, International Biodeterioration & Biodegradation, vol.120, pp.135-142, 2017.

I. S. Moreira, V. S. Bessa, S. Murgolo, C. Piccirillo, G. Mascolo et al., Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11, Ecotoxicology and Environmental Safety, vol.152, pp.104-113, 2018.

S. Aissaoui, H. Ouled-haddar, M. Sifour, K. Harrouche, and H. Sghaier, Metabolic and Co-metabolic transformation of diclofenac by enterobacter hormaechei D15 isolated from activated sludge, Current Microbiology, vol.74, issue.3, pp.381-388, 2017.

A. Nikolaou, S. Meric, and D. Fatta, Occurrence patterns of pharmaceuticals in water and wastewater environments, Analytical and Bioanalytical Chemistry, vol.387, issue.4, pp.1225-1234, 2007.

D. Dionisi, Potential and limits of biodegradation processes for the removal of organic xenobiotics from wastewaters, ChemBioEng Reviews, vol.1, issue.2, pp.67-82, 2014.

A. Barra-caracciolo, E. Topp, and P. Grenni, Pharmaceuticals in the environment: biodegradation and effects on natural microbial communities. A review, Journal of Pharmaceutical and Biomedical Analysis, vol.106, pp.25-36, 2015.

K. Stylianou, E. Hapeshi, M. I. Vasquez, D. Fatta-kassinos, and I. Vyrides, Diclofenac biodegradation by newly isolated Klebsiella sp. KSC: microbial intermediates and ecotoxicological assessment, Journal of Environmental Chemical Engineering, vol.6, issue.2, pp.3242-3248, 2018.

D. G. Larsson, C. De-pedro, and N. Paxeus, Effluent from drug manufactures contains extremely high levels of pharmaceuticals, Journal of Hazardous Materials, vol.148, issue.3, pp.751-755, 2007.

J. C. Spain and P. A. Van-veld, Adaptation of natural microbial communities to degradation of xenobiotic compounds: effects of concentration, exposure time, inoculum, and chemical structure, Applied and Environmental Microbiology, vol.45, issue.2, pp.428-435, 1983.

A. Joss, S. Zabczynski, and A. Göbel, Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme, Water Research, vol.40, issue.8, pp.1686-1696, 2006.

T. Kosjek, E. Heath, S. Pérez, M. Petrovi?, and D. Barceló, Metabolism studies of diclofenac and clofibric acid in activated sludge bioreactors using liquid chromatography with quadrupole-time-of-flight mass spectrometry, Journal of Hydrology, vol.372, issue.1-4, pp.109-117, 2009.

S. Pérez and D. Barceló, First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS, Analytical Chemistry, vol.80, issue.21, pp.8135-8145, 2008.

D. Stülten, S. Zühlke, M. Lamshöft, and M. Spiteller, Occurrence of diclofenac and selected metabolites in sewage effluents, Science of e Total Environment, vol.405, issue.1-3, pp.310-316, 2008.

H. Bouju, P. Nastold, B. Beck, J. Hollender, P. F. et al., Elucidation of biotransformation of diclofenac and 4?hydroxydiclofenac during biological wastewater treatment, Journal of Hazardous Materials, vol.301, pp.443-452, 2016.

R. Bort, K. Macé, A. Boobis, M. Gómez-lechón, A. Pfeifer et al., Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways, Biochemical Pharmacology, vol.58, issue.5, pp.787-796, 1999.

J. E. Prior, T. Shokati, U. Christians, and R. T. Gill, Identification and characterization of a bacterial cytochrome P450 for the metabolism of diclofenac, Applied Microbiology and Biotechnology, vol.85, issue.3, pp.625-633, 2010.

B. Bajrami, L. Zhao, J. B. Schenkman, and J. F. Rusling, Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format, Analytical Chemistry, vol.81, issue.24, pp.9921-9929, 2009.

J. Zi, D. Liu, and P. Ma, Effects of CYP2C9 * 3 and CYP2C9 * 13 on diclofenac metabolism and inhibition-based drug-drug interactions, Drug Metabolism and Pharmacokinetics, vol.25, issue.4, pp.343-350, 2010.

C. J. Sinclair and A. B. Boxall, Assessing the ecotoxicity of pesticide transformation products, Environmental Science & Technology, vol.37, issue.20, pp.4617-4625, 2003.

F. Desbiolles, L. Malleret, C. Tiliacos, P. Wong-wah-chung, and I. Laffont-schwob, Occurrence and ecotoxicological assessment of pharmaceuticals: is there a risk for the Mediterranean aquatic environment?, Science of e Total Environment, vol.639, pp.1334-1348, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02014313

B. Czech, I. Jo?ko, and P. Oleszczuk, Ecotoxicological evaluation of selected pharmaceuticals to Vibrio fischeri and Daphnia magna before and after photooxidation process, Ecotoxicology and Environmental Safety, vol.104, pp.247-253, 2014.

S. A. Ortiz-de-garcía, G. Pinto, P. A. García-encina, and R. Irusta-mata, Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants, Ecotoxicology, vol.23, issue.8, pp.1517-1533, 2014.

B. Ferrari, R. Mons, and B. Vollat, Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?, Environmental Toxicology and Chemistry, vol.23, issue.5, pp.1344-1354, 2004.

J. Schwaiger, H. Ferling, U. Mallow, H. Wintermayr, and R. D. Negele, Toxic effects of the non-steroidal anti-inflammatory drug diclofenac, Aquatic Toxicology, vol.68, issue.2, pp.141-150, 2004.

E. Praskova, E. Voslarova, and Z. Siroka, Assessment of diclofenac LC 50 reference values in juvenile and embryonic stages of the zebrafish (Danio rerio), Polish Journal of Veterinary Sciences, vol.14, issue.4, pp.545-549, 2011.

R. Feito, Y. Valcárcel, and M. Catalá, Biomarker assessment of toxicity with miniaturised bioassays: diclofenac as a case study, Ecotoxicology, vol.21, issue.1, pp.289-296, 2012.

W. F. Friedrich and E. P. Greenberg, Glucose repression of luminescence and luciferase in Vibrio fischeri, Archives of Microbiology, vol.134, issue.2, pp.87-91, 1983.

P. Joly, F. Bonnemoy, J. Charvy, J. Bohatier, and C. Mallet, Toxicity assessment of the maize herbicides S-metolachlor, benoxacor, mesotrione and nicosulfuron, and their corresponding commercial formulations, alone and in mixtures, using the Microtox ® test, Chemosphere, vol.93, issue.10, pp.2444-2450, 2013.